MoneyWorks4Me

Syngene International informs about update

23 Dec 2023 Evaluate

Syngene International has informed about update on the acquisition of biologics manufacturing facility from Stelis Biopharma. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sagility 43.40
Prime Focus 315.50
Knowledge RealtyTrt. 112.84
Indegene 612.95
Syngene Internatl. 375.75
View more..